Skip to content
  • About
  • Contact
  • Contribute
  • What Physicians Say
  • My Book
  • Careers
  • Podcast
  • Speaking
KevinMD.com — Social media's leading physician voice
  • All
  • Physician
  • Burnout
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • All
  • Physician
  • Burnout
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
    • All
    • Physician
    • Burnout
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • About
    • Contact
    • Contribute
    • What Physicians Say
    • My Book
    • Careers
    • Podcast
    • Speaking
KevinMD.com — Social media's leading physician voice
  • All
  • Physician
  • Burnout
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
    • All
    • Physician
    • Burnout
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • About
    • Contact
    • Contribute
    • What Physicians Say
    • My Book
    • Careers
    • Podcast
    • Speaking
  • About Kevin Pho, MD, Founder of KevinMD
  • Aging and dementia: what physicians say, in their own words
  • Artificial intelligence: what physicians say, in their own words
  • Be heard on social media’s leading physician voice
  • Board certification: what physicians say about the boards and MOC, in their own words
  • Cancer: what physicians say, in their own words
  • Children’s health: what pediatricians say, in their own words
  • Contact Kevin
  • COVID-19: what physicians wrote as it happened
  • Custom enhanced author page pricing
  • Diabetes and obesity: what physicians say, in their own words
  • Direct primary care: what physicians say, in their own words
  • DMCA Policy
  • End of life: what physicians say, in their own words
  • Establishing, Managing, and Protecting Your Online Reputation: A Social Media Guide for Physicians and Medical Practices
  • GLP-1 drugs: what physicians say about Ozempic and its successors, in their own words
  • Heart disease: what physicians say, in their own words
  • Immigration and medicine: what physicians say about immigrant doctors and immigrant patients, in their own words
  • KevinMD influencer opportunities
  • Medical errors: what physicians say, in their own words
  • Medical ethics: what physicians say, in their own words
  • Medical malpractice: what physicians say, in their own words
  • Medical school: what students and physicians say, in their own words
  • Mental health: what psychiatrists and physicians say, in their own words
  • Nursing: what nurses and physicians say, in their own words
  • Opinion and commentary by KevinMD
  • Opioids: what physicians and pain patients say, in their own words
  • Physician burnout speakers to keynote your conference
  • Physician burnout: what physicians say, in their own words
  • Physician careers: what physicians say about jobs, contracts, and leaving clinical practice, in their own words
  • Physician Coaching by KevinMD
  • Physician keynote speaker: Kevin Pho, MD
  • Physician personal finance: what physicians say about their own money, in their own words
  • Physician Speaking by KevinMD: a boutique speakers bureau
  • Physician suicide: what physicians say, in their own words
  • Physicians and administrators: what physicians say about who runs medicine, in their own words
  • Primary care physician in Nashua, NH | Kevin Pho, MD
  • Primary care: what physicians say, in their own words
  • Prior authorization: what physicians say, in their own words
  • Privacy Policy
  • Private equity and corporate medicine: what physicians say, in their own words
  • Race and medicine: what physicians say, in their own words
  • Recommended services by KevinMD
  • Residency: what residents and attendings say, in their own words
  • Scope of practice: what physicians, nurse practitioners, and PAs say, in their own words
  • Subscribe to the KevinMD enhanced author page
  • Subscribe to the newsletter
  • Surgeons and surgery: what surgeons say, in their own words
  • Take-home messages: what physicians say when asked to leave one
  • Terms of Use Agreement
  • Thank you for subscribing to KevinMD
  • Thank you for upgrading to the KevinMD enhanced author page
  • The electronic health record: what physicians say, in their own words
  • Vaccines: what physicians say, in their own words
  • Violence against health care workers: what physicians and nurses say, in their own words
  • What physicians say: the KevinMD records
  • Women in medicine: what women physicians say, in their own words
  • Women’s health: what physicians say, in their own words

Ethylene in plants and animals: one molecule, two stories

Rao M. Uppu, PhD
Conditions and Diseases
June 24, 2026
Share
Tweet
Share

Ethylene is one of the simplest organic molecules, yet it has remarkably different meanings in plants and animals. I first became interested in ethylene during my predoctoral years because of its familiar role in fruit ripening. My interest took a different direction during my early research years at Louisiana State University and later at Southern University, when I began examining how ethylene may arise through oxidative chemistry and its possible significance in the biomedical sciences. The same molecule can therefore tell two very different biological stories.

A regulated hormone in plants

Although it took decades of research to understand the process, plants are now known to possess a dedicated and tightly regulated pathway for ethylene biosynthesis and signaling.

Methionine is first converted to S-adenosylmethionine and then to 1-aminocyclopropane-1-carboxylic acid, commonly known as ACC, before the final formation of ethylene. Adams and Yang’s identification of ACC as the intermediate linking methionine to ethylene was a decisive step in mapping this pathway.

Once produced, ethylene is recognized through specialized receptors and signaling pathways. The identification of the Arabidopsis ETR1 gene helped explain how plants perceive ethylene and translate its presence into coordinated biological responses.

Ethylene regulates fruit ripening, senescence, abscission, seed germination, growth, development, and responses to environmental stress. Its importance in fruit ripening was recognized well before the details of its biosynthetic and signaling pathways were known.

Because ethylene is a gas, its influence is not necessarily confined to the tissue in which it is produced. It can move through surrounding air spaces and affect nearby fruits and plant tissues. This gives ethylene importance not only within an individual plant but also in crop production, harvesting, storage, transportation, and postharvest management.

Long before the chemistry was understood, people had learned to make practical use of its effects. Historical accounts describe the burning of incense in enclosed rooms in ancient China to hasten the ripening of pears. In the 1920s, researchers observed that warming citrus fruit with kerosene heaters in enclosed spaces caused peel degreening that could not be explained by heat alone. The effect was subsequently attributed to ethylene present in the combustion gases.

Understanding and controlling ethylene has enormous economic importance. Ethylene production, exposure, and perception influence fruit ripening, color, firmness, storage, transportation, shelf life, market quality, and postharvest losses. Better management of ethylene can help coordinate harvesting, preserve agricultural produce, and reduce unnecessary chemical interventions.

That economic importance can also create incentives for crude and potentially unsafe shortcuts. One troubling example is the use of calcium carbide to hasten fruit ripening. When calcium carbide is placed in or near fruit crates or ripening rooms, it reacts with moisture to release acetylene, not ethylene. Acetylene can nevertheless mimic some of ethylene’s ripening effects. Unlike controlled treatment with ethylene gas, the use of calcium carbide is prohibited in India because of its potential health risks. The Food Safety and Standards Authority of India has called for inspections of fruit markets, storage facilities, wholesalers, and distributors to prevent its use.

Ethylene as a product of oxidative chemistry in animals

Animals, including humans, do not appear to possess a comparable endogenous ethylene hormone or receptor-mediated signaling system. Instead, ethylene may be generated during oxidative processes, including lipid peroxidation and the oxidation of methionine-related compounds.

My interest in this question has roots in the early free-radical literature and in my association with the late Professor William A. Pryor. The issue was not simply whether oxidative systems could produce ethylene, but which oxidants were actually responsible.

One of the early mechanistic studies was reported by Charles Beauchamp and Irwin Fridovich in 1970. They demonstrated ethylene formation from methional in a xanthine-xanthine oxidase system and proposed that hydroxyl radical was responsible for the transformation. Their work helped establish methional-derived ethylene as a probe for studying oxygen-radical reactions.

ADVERTISEMENT

Later, Pryor, Jin, and Squadrito examined the peroxynitrite-mediated oxidation of methionine and its analog, 2-keto-4-methylthiobutyric acid (KTBA). They showed that the reactions could follow competing pathways: a two-electron pathway producing the corresponding sulfoxide and a one-electron pathway ultimately producing ethylene. These studies provided an important chemical foundation for considering ethylene as a product of oxidative reactions in biological systems.

The biomedical relevance of this chemistry was illustrated in an experimental study in rats. Following intragastric administration of ferrous sulfate, hydroxyl-radical-like activity was assessed through the conversion of KTBA to ethylene. Ascorbic acid, which is often combined with oral iron to help maintain iron in a reduced and more readily absorbable form, exerted concentration-dependent effects in vitro, enhancing ethylene formation at lower concentrations while suppressing it at higher concentrations. In the corresponding animal experiments, its radical-scavenging action was more prominent. These findings underscore the complex redox chemistry that can accompany iron administration, particularly when some of the administered iron remains unabsorbed in the gastrointestinal tract.

Ethylene has also been detected in exhaled breath, including in humans. A controlled human study found increased breath ethylene during experimentally induced systemic inflammation. Its presence may therefore provide information about oxidative activity and could have value as a noninvasive indicator of oxidative stress. Considerably more work is needed, however, before breath ethylene can be regarded as a validated clinical biomarker.

Which radical oxidant is responsible?

This question remained with me: What is the actual one-electron oxidant responsible for ethylene formation in peroxynitrite reactions?

Before the importance of carbon dioxide in peroxynitrite chemistry was fully recognized, ethylene formation had been attributed to an undefined activated intermediate of peroxynitrous acid, sometimes represented as ONOOH*. With advances in peroxynitrite chemistry, it became reasonable to ask whether this elusive oxidant might instead be carbonate radical, nitrogen dioxide, or some combination of the two.

The work presented in my 2023 Society of Toxicology poster, “On the Nature of Free Radical Oxidant(s) Responsible for Ethylene Production in Peroxynitrite-CO2 Reactions with Methionine and Its Analogs,” examined ethylene formation during reactions of peroxynitrite with methionine, KTBA, and selenomethionine. The reactions were performed in sealed vials, and ethylene in the headspace was measured by gas chromatography with flame-ionization detection.

The substrates behaved very differently. Using the ethylene yield from KTBA as 100 percent, the relative yields from methionine and selenomethionine were only about 14 percent and 1 percent, respectively. Decomposed peroxynitrite produced no detectable ethylene, confirming that active oxidant chemistry was required.

One result was particularly interesting. For a given substrate, ethylene production was essentially similar whether or not bicarbonate was added to the reaction mixture. Thus, adding bicarbonate did not by itself increase the amount of ethylene formed.

The competition experiments provided the most useful mechanistic clues. 2,2′-Azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS), acting as a competing one-electron donor, strongly inhibited ethylene production. The phenolic compound 4-hydroxyphenylacetic acid also inhibited the reaction, and the combination of the two produced near-complete inhibition under the conditions examined. The patterns were similar in reactions performed with or without added bicarbonate.

Propanal (40 mM) was examined as a carbonyl surrogate for carbon dioxide in the peroxynitrite-KTBA reaction. It reduced ethylene formation by approximately 88 percent, indicating that intermediates generated in the peroxynitrite-propanal reaction were much less efficient in promoting the one-electron oxidation of KTBA.

These observations led us to favor carbonate radical as a major one-electron oxidant involved in ethylene production in these model reactions. The findings did not exclude contributions from nitrogen dioxide or other intermediates, but they were consistent with the action of a potent and comparatively selective one-electron oxidant.

Carbonate radical is generally less reactive than hydroxyl radical but more selective. That selectivity may be important in biological systems, where the most reactive oxidant is not necessarily the one that determines the observed product.

The work extended the earlier studies of Beauchamp and Fridovich and of Pryor and colleagues. It suggested that ethylene formation may arise from identifiable free-radical pathways rather than from an undefined or purely random oxidative process.

One molecule, two biological stories

To me, the central point is not simply that plants and animals produce the same molecule through different routes. It is that ethylene carries two different biological meanings.

In plants, ethylene is purposefully produced, perceived, and regulated. It coordinates ripening, growth, senescence, abscission, and responses to environmental stress. Its management also carries major agricultural and economic consequences.

In animals, the same molecule may arise as an incidental product of ongoing or episodic free-radical oxidation. Rather than functioning as a known hormone, it may provide a chemical record of oxidative activity, inflammation, or molecular injury.

Ethylene therefore represents a regulated signal in plants and a possible footprint of oxidative chemistry in animals.

This work also reflects the lasting influence of Professor William A. Pryor, whose pioneering contributions to free-radical chemistry shaped my continuing interest in oxidative biology. Parts of the experimental work were carried out in his laboratory at Louisiana State University. I also gratefully acknowledge Dr. Rafael Cueto for his indispensable assistance with GC-FID analysis.

Rao M. Uppu is professor of environmental toxicology and chemistry at Southern University and A&M College in Baton Rouge, Louisiana, where he has served since 2002. He is also an adjunct professor of chemistry and pathobiological sciences at Louisiana State University.

Trained in biochemistry, physical organic chemistry, and free radical chemistry, his research spans bioanalytical methods, biomarker discovery and validation, chemical toxicology, environmental chemistry, computational genomics, reactive intermediates, and the molecular mechanisms of disease. His scholarship is indexed on ORCID, ResearchGate, and Google Scholar.

Dr. Uppu is a Fellow of the American Association for the Advancement of Science (AAAS), the Royal Society of Chemistry (RSC), the Royal Society of Biology (RSB), the Royal Society of Medicine (RSM), the Royal Society for Public Health (RSPH), and the Academy of Toxicological Sciences (ATS).

In addition to his scientific research, he writes reflective essays on scientific culture, mentorship, peer review, ethics, and the human dimensions of academic life. He shares updates on LinkedIn.

Tagged as: Medical School

< Previous Post
Compassion fatigue is evidence of caring, not failing
Next Post >
Language barriers in health care begin with the effort

 

ADVERTISEMENT

More by Rao M. Uppu, PhD

  • AI in peer review should be a second reader, not a judge

    Rao M. Uppu, PhD
  • AI in scientific writing: Assistance is not authorship

    Rao M. Uppu, PhD
  • Frontier AI oversight must match real-world risk

    Rao M. Uppu, PhD

Related Posts

  • Ketamine for mental health conditions: What every primary care physician needs to know

    Carlene MacMillan, MD & L. Alison McInnes, MD
  • KevinMD on PermanenteDocs Chat [PODCAST]

    The Podcast by KevinMD

More in Conditions and Diseases

  • Blood sugar and brain aging start long before diabetes

    Hana Kahleova, MD, PhD, MBA
  • Why is psychic pain treated as a symptom instead of pain?

    Michelle Wyrick, RN
  • Cancer care in Ghana: Poverty is the true malignancy

    Nana Akua Acquaye
  • Why choose sleep medicine as an intellectual frontier

    Bruce D. Forman, PhD
  • After 2 failed antidepressants, raise TMS and esketamine

    Ravi Singareddy, MD
  • Stop calling every form of physician distress burnout

    Devina Maya Wadhwa, MD
  • Most Popular

  • Past Week

    • The conflict of interest that discloses as nothing

      Martha Rosenberg | Medications
    • How to reassure patients: 5 steps beyond normal tests

      Devina Maya Wadhwa, MD | Physician
    • Why patients stop trusting doctors who listened to them [PODCAST]

      The Podcast by KevinMD | Podcast
    • AI in prior authorization: 3 contract questions for 2027

      Matt Hasan, PhD | Health Policy
    • How to build a dementia care pathway, not a referral sheet

      Gerald Kuo | Health Policy
    • Underage online gambling needs more than a checkbox

      Kayvan Haddadan, MD | Conditions and Diseases
  • Past 6 Months

    • Why CDC opioid guidelines get the overdose data wrong

      Richard A. Lawhern, PhD | Conditions and Diseases
    • Retirement isn’t the end of medicine, it’s a second act [PODCAST]

      The Podcast by KevinMD | Podcast
    • Sensory processing in autism and the brain’s volume control

      Josette Pelatan, PhD | Conditions and Diseases
    • What maternity care deserts cost a town

      Manisha Kaliaperumal | Health Policy
    • Why medicine needs a national physician license now

      Vaishali Popat, MD, MPH | Physician
    • A cold cost $945. The cost of primary care is broken.

      Susan Newman, MD | Physician
  • Recent Posts

    • Why patients stop trusting doctors who listened to them [PODCAST]

      The Podcast by KevinMD | Podcast
    • Blood sugar and brain aging start long before diabetes

      Hana Kahleova, MD, PhD, MBA | Conditions and Diseases
    • What did the tirzepatide study actually test?

      Jeffrey Laman, MD | Medications
    • Why is psychic pain treated as a symptom instead of pain?

      Michelle Wyrick, RN | Conditions and Diseases
    • Diagnostic overshadowing and the war in her throat

      Diagnostic overshadowing and the war in her throat

      Franklyn R. Gergits, DO, MBA | Physician
    • Why do charity commercials leave clinicians uneasy?

      Why do charity commercials leave clinicians uneasy?

      Ronald L. Lindsay, MD | Physician

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

Leave a Comment

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

  • Most Popular

  • Past Week

    • The conflict of interest that discloses as nothing

      Martha Rosenberg | Medications
    • How to reassure patients: 5 steps beyond normal tests

      Devina Maya Wadhwa, MD | Physician
    • Why patients stop trusting doctors who listened to them [PODCAST]

      The Podcast by KevinMD | Podcast
    • AI in prior authorization: 3 contract questions for 2027

      Matt Hasan, PhD | Health Policy
    • How to build a dementia care pathway, not a referral sheet

      Gerald Kuo | Health Policy
    • Underage online gambling needs more than a checkbox

      Kayvan Haddadan, MD | Conditions and Diseases
  • Past 6 Months

    • Why CDC opioid guidelines get the overdose data wrong

      Richard A. Lawhern, PhD | Conditions and Diseases
    • Retirement isn’t the end of medicine, it’s a second act [PODCAST]

      The Podcast by KevinMD | Podcast
    • Sensory processing in autism and the brain’s volume control

      Josette Pelatan, PhD | Conditions and Diseases
    • What maternity care deserts cost a town

      Manisha Kaliaperumal | Health Policy
    • Why medicine needs a national physician license now

      Vaishali Popat, MD, MPH | Physician
    • A cold cost $945. The cost of primary care is broken.

      Susan Newman, MD | Physician
  • Recent Posts

    • Why patients stop trusting doctors who listened to them [PODCAST]

      The Podcast by KevinMD | Podcast
    • Blood sugar and brain aging start long before diabetes

      Hana Kahleova, MD, PhD, MBA | Conditions and Diseases
    • What did the tirzepatide study actually test?

      Jeffrey Laman, MD | Medications
    • Why is psychic pain treated as a symptom instead of pain?

      Michelle Wyrick, RN | Conditions and Diseases
    • Diagnostic overshadowing and the war in her throat

      Diagnostic overshadowing and the war in her throat

      Franklyn R. Gergits, DO, MBA | Physician
    • Why do charity commercials leave clinicians uneasy?

      Why do charity commercials leave clinicians uneasy?

      Ronald L. Lindsay, MD | Physician

Copyright © 2026 KevinMD.com | Powered by Astra WordPress Theme

  • Terms of Use Agreement
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Leave a Comment

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...